473 related articles for article (PubMed ID: 28318408)
1. Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Immune-Mediated Liver Injury and Compromise Virus Control During Acute Hepatitis B Virus Infection in Mice.
Qu M; Yuan X; Liu D; Ma Y; Zhu J; Cui J; Yu M; Li C; Guo D
Stem Cells Dev; 2017 Jun; 26(11):818-827. PubMed ID: 28318408
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived mesenchymal stem cells suppress NK cell recruitment and activation in PolyI:C-induced liver injury.
Qu M; Cui J; Zhu J; Ma Y; Yuan X; Shi J; Guo D; Li C
Biochem Biophys Res Commun; 2015 Oct; 466(2):173-9. PubMed ID: 26342798
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressive Effects of Mycophenolate Mofetil and Hepatitis B Virus Infection.
Dong S; Geng L; Shen MD; Zheng SS
Am J Med Sci; 2015 May; 349(5):432-7. PubMed ID: 25828197
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infection.
Liu D; Liu L; Wang L; Duan S; Song Y; Qu M; Gao N; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
Mol Med Rep; 2018 Jan; 17(1):1731-1741. PubMed ID: 29257255
[TBL] [Abstract][Full Text] [Related]
5. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressant Effect of Mycophenolate Mofetil and Infection of Hepatitis B Virus.
Dong S; Geng L; Shen MD; Zheng SS
Transplant Proc; 2015; 47(6):1796-801. PubMed ID: 26293053
[TBL] [Abstract][Full Text] [Related]
9. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
10. Liver mesenchymal stem cells are superior inhibitors of NK cell functions through differences in their secretome compared to other mesenchymal stem cells.
Yigitbilek F; Ozdogan E; Abrol N; Park WD; Hansen MJ; Dasari S; Stegall MD; Taner T
Front Immunol; 2022; 13():952262. PubMed ID: 36211345
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
13. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
15. Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function.
Petri RM; Hackel A; Hahnel K; Dumitru CA; Bruderek K; Flohe SB; Paschen A; Lang S; Brandau S
Stem Cell Reports; 2017 Sep; 9(3):985-998. PubMed ID: 28781075
[TBL] [Abstract][Full Text] [Related]
16. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.
Weinger JG; Plaisted WC; Maciejewski SM; Lanier LL; Walsh CM; Lane TE
Stem Cells; 2014 Oct; 32(10):2690-701. PubMed ID: 24898518
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.
Blanco B; Herrero-Sánchez MD; Rodríguez-Serrano C; García-Martínez ML; Blanco JF; Muntión S; García-Arranz M; Sánchez-Guijo F; Del Cañizo C
Eur J Haematol; 2016 Dec; 97(6):528-537. PubMed ID: 27118602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]